ACB Aurora Cannabis: 5 Stock Triggers After Curaleaf Bid - Thursday Predicted Opening Price?🚨
1 extracted signal · 0 resolved · 1 still active
StockInvest.usIndependent analyst profile- Source published
- 22 Oct 2026, 00:30 UTC
- Recorded by Tahlil Plus
- 22 Oct 2026, 03:21 UTC
AI-generated source summary
The Aurora Cannabis (ACB) stock displays numerous negative technical signals from both short-term and long-term moving averages, suggesting a more negative forecast. On upward corrections, resistance is observed at $4.06 and $4.01. A break above these levels could signal buy opportunities. However, a sell signal was issued from a pivot top on October 6, 2026, leading to a 13.73% drop. Further declines are anticipated until a new bottom pivot is identified. A current sell signal from the 3-month MACD indicates potential further downside. Volume increased on falling prices, suggesting caution. The stock shows mixed signals from various indicators, with a predominant bearish outlook. Short-term and long-term moving averages suggest a sell, while the MACD indicates a sell signal. The stock's price is currently below its 50-day and 200-day moving averages, indicating a bearish trend. The P/E ratio is negative (-2.72), indicating losses. The 52-week range is $2.56 to $6.36, with the current price near the lower end. The stock faces resistance at $4.01 and support at $3.94.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.